Latest Talk
Enabling Scalable & Cost-Effective Point of Care for Cell & Gene Therapies
The transformative potential to change the way human disease is treated using cell and gene therapy has motivated rapid technological advancements towards streamlining manufacturing processes. Standardization via automation and introduction of quality control via closed system manufacturing will contribute to overcoming barriers and facilitate the reach of this treatment to broader patient populations. In this…
